adplus-dvertising
Connect with us

Business

COVID-19: B.C. hit with 'overwhelming' response to book AstraZeneca vaccines – Vancouver Sun

Published

 on


Starting today people aged 55 to 65 living in the Lower Mainland can book a vaccine but people can expect delays and waitlists to book a jab.

Article content

Starting today people aged 55 to 65 living in the Lower Mainland can book an AstraZeneca/COVISHIELD vaccine, but so far the rollout has not gone smoothly.

Frustrated folks in the region faced busy phone signals at pharmacies, jammed websites, waitlists, and at least one pharmacy chain saying it was all booked up.

On Tuesday night, a day before the bookings opened for this category, London Drugs announced on Twitter that due to an “overwhelming response,” all vaccine appointments had been booked at the three London Drugs pharmacies selected by the B.C. government to offer the vaccine.

The company asked people not to call the pharmacies so they can prepare for the “fully booked” appointments.

Those who felt confused or daunted by the process took to social media to complain about the booking system. Some were upset about London Drugs booking on Tuesday ahead of the Wednesday start, while others despaired over not being able to get a booking because the pharmacy had already run out of AstraZeneca.

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

There are dozens of pharmacies around the region offering the jab. The B.C. Pharmacy Association website has a list of pharmacies offering the vaccine, which will be updated regularly in the coming weeks.

However, callers to several pharmacies on the list were met with a busy signal Wednesday morning, indicating a demand for the vaccine.

The 2019 population data for those aged 55 to 65 in the Lower Mainland show there are 275,457 people in that age category in the Fraser Health Authority and 176,431 in Vancouver Coastal.

Those trying for an appointment on the North Shore faced difficulties. For instance, Davies Prescription Pharmacy, which is one of two North Shore pharmacies on the vaccination list, said they were out of a very limited supply of AstraZeneca vaccine on Wednesday morning, while the other one on the list is a London Drugs, which is booked. There is no pharmacy listed for West Vancouver.

The Costco Pharmacy in Abbotsford said they haven’t received any AstraZeneca yet and directed people to add their name to a waitlist at costco.ca.  Rexall pharmacies also has a waitlist.

The Ministry of Health has been contacted to address the situation.

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

Interim leader of the Official Opposition Shirley Bond and MLA Renee Merrifield, the B.C. Liberal critic for health, released a joint statement Wednesday, saying the NDP’s “constant bungling” is creating confusion and concern over vaccinations.

The government announced Tuesday that those in the age 55 to 65 category could start booking vaccines, but many pharmacies were overwhelmed or didn’t know they were on the vaccination list, they said.

“For weeks we have consistently been asking John Horgan to include community pharmacies as part of the rollout and to have a clearly laid out plan. That didn’t happen and British Columbians deserve better. Yesterday was just another example of incompetence from a government that cannot manage to deliver on critical programs like the vaccination rollout, they said.

“Now the 55 to 65 age cohort in the Lower Mainland is left wondering what happened after feeling a sense of hope about the possibility of being vaccinated. We can certainly understand how people are feeling frustration and anger about the latest problems with the vaccination rollout.”

Bond and Merrifield said there needs to be a provincial booking system.

London Drugs’ announcement caused many social media users to express frustration about how people could book on Tuesday when they were told by government that bookings opened on Wednesday.

The company has been contacted for a response but has not yet returned messages.

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

The province decided to bump up its age-based immunization plan for AstraZeneca shots after concerns about rare blood clots prompted the National Advisory Committee on Immunization to pause the use of the vaccine for anyone under 55.

Provincial health officer Dr. Bonnie Henry says in a news release that the vaccine remains highly effective and its benefits for those over 55 far outweigh the risks of COVID-19 infection.

More than 99,000 B.C. residents have been diagnosed with COVID-19 since the start of the pandemic and infections have surged across the province in recent weeks, with 840 new cases reported Tuesday.

“As soon as the news was public all of our Lower Mainland British Columbia stores became inundated with customers wanting to book appointments,” London Drugs said on Twitter.

London Drugs said its three designated vaccination sites in Metro Vancouver have received limited allocations of the AstraZeneca vaccine.

“As soon as more supply becomes available, we will open up our online booking similarly to what we would do with routine flu vaccinations. We are ready to vaccinate as many people as possible and expect more information on increased allotment will be coming in the days ahead.”

Those going to get a vaccine will be required to bring their Personal Health Number, located on your CareCard or driver’s license.

The AstraZeneca/COVISHIELD vaccine is currently not available in pharmacies in the Northern, Interior, and Vancouver Island health authorities at this time.

-with files from The Canadian Press and Nathan Griffiths

ticrawford@postmedia.com


Get the latest COVID-19 news delivered to your inbox weeknights at 7 p.m. by subscribing to our newsletter here.


  1. A health worker prepares a dose of the AstraZeneca vaccine in Madrid on March 24, 2021.

    COVID-19: Dr. Henry explains future of parallel AstraZeneca track

  2. The provincial health officer, Dr. Bonnie Henry.

    COVID-19: Health Ministry mum on call to change vaccination priorities in B.C.

Comments

Postmedia is committed to maintaining a lively but civil forum for discussion and encourage all readers to share their views on our articles. Comments may take up to an hour for moderation before appearing on the site. We ask you to keep your comments relevant and respectful. We have enabled email notifications—you will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments. Visit our Community Guidelines for more information and details on how to adjust your email settings.

Let’s block ads! (Why?)

728x90x4

Source link

Continue Reading

Business

Canada Goose to get into eyewear through deal with Marchon

Published

 on

 

TORONTO – Canada Goose Holdings Inc. says it has signed a deal that will result in the creation of its first eyewear collection.

The deal announced on Thursday by the Toronto-based luxury apparel company comes in the form of an exclusive, long-term global licensing agreement with Marchon Eyewear Inc.

The terms and value of the agreement were not disclosed, but Marchon produces eyewear for brands including Lacoste, Nike, Calvin Klein, Ferragamo, Longchamp and Zeiss.

Marchon plans to roll out both sunglasses and optical wear under the Canada Goose name next spring, starting in North America.

Canada Goose says the eyewear will be sold through optical retailers, department stores, Canada Goose shops and its website.

Canada Goose CEO Dani Reiss told The Canadian Press in August that he envisioned his company eventually expanding into eyewear and luggage.

This report by The Canadian Press was first published Sept. 19, 2024.

Companies in this story: (TSX:GOOS)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

A timeline of events in the bread price-fixing scandal

Published

 on

 

Almost seven years since news broke of an alleged conspiracy to fix the price of packaged bread across Canada, the saga isn’t over: the Competition Bureau continues to investigate the companies that may have been involved, and two class-action lawsuits continue to work their way through the courts.

Here’s a timeline of key events in the bread price-fixing case.

Oct. 31, 2017: The Competition Bureau says it’s investigating allegations of bread price-fixing and that it was granted search warrants in the case. Several grocers confirm they are co-operating in the probe.

Dec. 19, 2017: Loblaw and George Weston say they participated in an “industry-wide price-fixing arrangement” to raise the price of packaged bread. The companies say they have been co-operating in the Competition Bureau’s investigation since March 2015, when they self-reported to the bureau upon discovering anti-competitive behaviour, and are receiving immunity from prosecution. They announce they are offering $25 gift cards to customers amid the ongoing investigation into alleged bread price-fixing.

Jan. 31, 2018: In court documents, the Competition Bureau says at least $1.50 was added to the price of a loaf of bread between about 2001 and 2016.

Dec. 20, 2019: A class-action lawsuit in a Quebec court against multiple grocers and food companies is certified against a number of companies allegedly involved in bread price-fixing, including Loblaw, George Weston, Metro, Sobeys, Walmart Canada, Canada Bread and Giant Tiger (which have all denied involvement, except for Loblaw and George Weston, which later settled with the plaintiffs).

Dec. 31, 2021: A class-action lawsuit in an Ontario court covering all Canadian residents except those in Quebec who bought packaged bread from a company named in the suit is certified against roughly the same group of companies.

June 21, 2023: Bakery giant Canada Bread Co. is fined $50 million after pleading guilty to four counts of price-fixing under the Competition Act as part of the Competition Bureau’s ongoing investigation.

Oct. 25 2023: Canada Bread files a statement of defence in the Ontario class action denying participating in the alleged conspiracy and saying any anti-competitive behaviour it participated in was at the direction and to the benefit of its then-majority owner Maple Leaf Foods, which is not a defendant in the case (neither is its current owner Grupo Bimbo). Maple Leaf calls Canada Bread’s accusations “baseless.”

Dec. 20, 2023: Metro files new documents in the Ontario class action accusing Loblaw and its parent company George Weston of conspiring to implicate it in the alleged scheme, denying involvement. Sobeys has made a similar claim. The two companies deny the allegations.

July 25, 2024: Loblaw and George Weston say they agreed to pay a combined $500 million to settle both the Ontario and Quebec class-action lawsuits. Loblaw’s share of the settlement includes a $96-million credit for the gift cards it gave out years earlier.

Sept. 12, 2024: Canada Bread files new documents in Ontario court as part of the class action, claiming Maple Leaf used it as a “shield” to avoid liability in the alleged scheme. Maple Leaf was a majority shareholder of Canada Bread until 2014, and the company claims it’s liable for any price-fixing activity. Maple Leaf refutes the claims.

This report by The Canadian Press was first published Sept. 19, 2024.

Companies in this story: (TSX:L, TSX:MFI, TSX:MRU, TSX:EMP.A, TSX:WN)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

TD CEO to retire next year, takes responsibility for money laundering failures

Published

 on

 

TORONTO – TD Bank Group, which is mired in a money laundering scandal in the U.S., says chief executive Bharat Masrani will retire next year.

Masrani, who will retire officially on April 10, 2025, says the bank’s, “anti-money laundering challenges,” took place on his watch and he takes full responsibility.

The bank named Raymond Chun, TD’s group head, Canadian personal banking, as his successor.

As part of a transition plan, Chun will become chief operating officer on Nov. 1 before taking over the top job when Masrani steps down at the bank’s annual meeting next year.

TD also announced that Riaz Ahmed, group head, wholesale banking and president and CEO of TD Securities, will retire at the end of January 2025.

TD has taken billions in charges related to ongoing U.S. investigations into the failure of its anti-money laundering program.

This report by The Canadian Press was first published Sept. 19, 2024.

Companies in this story: (TSX:TD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending